1. Mitral valve in hypertrophic cardiomyopathy: a three-dimensional transesophageal study
- Author
-
Aris Anastasakis, Christodoulos Stefanadis, Erifili Venieri, Constantina Aggeli, Helen Sambatakou, and Dimitrios Tousoulis
- Subjects
lcsh:Diseases of the circulatory (Cardiovascular) system ,medicine.medical_specialty ,Group ii ,systolic anterior motion ,Echocardiography, Three-Dimensional ,030204 cardiovascular system & hematology ,Ventricular Outflow Obstruction ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Mitral valve ,left ventricular outflow tract obstruction ,medicine ,Humans ,In patient ,cardiovascular diseases ,030212 general & internal medicine ,business.industry ,Hypertrophic cardiomyopathy ,Mitral Valve Insufficiency ,Cardiomyopathy, Hypertrophic ,hypertrophic cardiomyopathy ,medicine.disease ,medicine.anatomical_structure ,lcsh:RC666-701 ,3D transesophageal echocardiography ,cardiovascular system ,Cardiology ,Mitral Valve ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background: It is reported that the mitral valve (MV) in hypertrophic cardiomyopathy (HCM) has structural abnormalities. Purpose: To assess the MV in HCM patients using Three-Dimensional Transesophageal Echocardiography (3DTEE). Methods: Transthoracic and 3DTEE studies focused on the mitral valve were performed prospectively in 21 HCM patients with obstruction (Group I), 37 HCM patients without obstruction (Group II) and 28 controls (Group III). Results: The aortomitral angle was less obtuse in groups I and II compared with group III (104.6 ± 6.7° vs 107.6 ± 8.5° vs 112.9 ± 3.2°, p
- Published
- 2019